Press release
MASORI Therapeutics Announces Generative AI Solutions Proven to Drive Healthcare and Pharma Sales, Growth, and Profits
HENDERSON, Nev. and TOKYO, Japan - April 16, 2025 - Masori Therapeutics today announced the debut of its new suite of generative artificial intelligence (GenAI) solutions, which are proven to drive sales and revenue growth for healthcare and pharma businesses. With powerful AI, Masori Therapeutics empowers pharma brands to merge smart data with precise and actionable targeting. The solutions use AI to analyze the most current data to develop actionable insights, optimize decision-making, and enhance outcomes across the pharmaceutical landscape.
"Our mission is simple, to help life science companies unlock the full potential of AI technology, creating impactful touchpoints across the patient journey," said Dane D. Hallberg, Executive Chairman and CEO of Masori Therapeutics. "AI-powered solutions support brands in engaging healthcare professionals (HCPs) at key moments. The goals are optimal patient outcome and sustained business growth for healthcare businesses."
One Masori Therapeutics client reported positive double-digit prescription growth using the MASORI GO NBA (next best action) field sales alert and targeting system. This success story highlights how Masori Therapeutics' decades of healthcare and pharmaceutical industry experience translate into innovation. By incorporating robust customer relationship management (CRM) capabilities into the GenAI toolset, Masori Therapeutics enables personalized engagement and streamlined communication with healthcare providers-driving gains in market share, elevating HCP relationships, and ensuring a meaningful impact on patient care.
The Masori AI Chatbot revolutionizes interaction between patients and HCPs, for better compliance and intuitive engagement.
Key benefits of the new AI technology include:
- First mover advantage
- Enhanced engagement
- Simplified access
- Medical, legal, and regulatory standards
- Cost and time efficiency
- Omnichannel integration and real-time feedback from field teams
For more information and an opportunity for a demonstration, visit www.MASORI.com [http://www.masori.com/]
Media Contact
Company Name: Masori Therapeutics
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=masori-therapeutics-announces-generative-ai-solutions-proven-to-drive-healthcare-and-pharma-sales-growth-and-profits]
Country: United States
Website: http://www.MASORI.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MASORI Therapeutics Announces Generative AI Solutions Proven to Drive Healthcare and Pharma Sales, Growth, and Profits here
News-ID: 3974634 • Views: …
More Releases from Getnews
New Book Explores the Ancient Hebrew Name of God and the Scriptural Evidence for …
Image: https://www.aionewswire.com/storage/images/ckeditor//9798892287463-Perfect_1765382027.jpg
A new thought-provoking work, The Mystery of God's Ancient Hebrew Name and Reincarnation Proven in the Scriptures [https://www.amazon.com/dp/B0G1ZDX9YR], dives deeply into two of the most debated and often misunderstood subjects in faith discussions: the original Hebrew name of the Creator and the presence of reincarnation within biblical texts. Drawing from years of study, cross-referenced Scripture, and linguistic research, author Chet Netherly presents a compelling examination centered on restoring long-overlooked…
A Heartfelt Journey Into the Mind of a Young Dreamer Todd Michael Begin Releases …
Image: https://www.aionewswire.com/storage/images/ckeditor//85905104270_1765380679.jpg
Northern Ontario author and longtime educator Todd Michael Begin invites readers into a touching, imaginative, and deeply human story in his debut children's book, My World is Home [https://www.amazon.com/World-Home-Middle-School-Author/dp/1038343143]. Blending slice of life storytelling with whimsical fantasy, Begin captures a week in the life of a young boy who navigates everyday challenges while escaping into a world of vivid daydreams where ordinary people become creatures, friends, or heroes.
Written with…
Federixa & BEAX release their electronic music
Image: https://www.globalnewslines.com/uploads/2025/12/5f95777dcc1e2dcc357a8a1d12fb3e49.jpg
Experimentation and creativity with over 100 official tracks at just 10 and 8 years old
Federixa (10 years old) and BEAX (8 years old) are two young Italian producers and songwriters with an overwhelming passion for electronic music. They don't sing, but they produce, write, and create original sounds ranging from Tech House to Melodic Techno, from Electro Dance to Electronic Hip Hop. Despite their young age, they are already…
brainSHARE Founder and Chamber Board Member Joe Siecinski Launches Complimentary …
Image: https://www.globalnewslines.com/uploads/2025/12/1765328151.jpg
"I can't stop the business ground from shifting. But through this program, I can help owners strengthen the systems and human connection they need to find their footing and move forward with confidence. That's why this matters now more than ever." - Joe Siecinski, Founder: brainShare Business Mentors.
brainSHARE Founder Joe Siecinski is offering new Silicon Valley Chamber members two months of free access to The Success Circle, helping business…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
